IBM
55
-2
O
37
-2
BBY
32
-5
KIM
51
-3
GWW
39
-2
DOW
46
2
EXC
76
6
AVGO
52
17
GT
37
-4
DRI
60
-7
HD
38
-5
MU
51
-4
BXP
33
-6
CRM
34
-5
ISRG
54
-3
KO
55
-4
DHI
36
-3
ADBE
38
-12
JBHT
35
-4
MCD
55
-4
IBM
55
-2
O
37
-2
BBY
32
-5
KIM
51
-3
GWW
39
-2
DOW
46
2
EXC
76
6
AVGO
52
17
GT
37
-4
DRI
60
-7
HD
38
-5
MU
51
-4
BXP
33
-6
CRM
34
-5
ISRG
54
-3
KO
55
-4
DHI
36
-3
ADBE
38
-12
JBHT
35
-4
MCD
55
-4
Financhill
Back

Haemonetics 10K Form

Buy
58

HAE
Haemonetics

Last Price:
$65.95
Seasonality Move:
1.15%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-08 10Q HAE/Haemonetics Quarterly
2023-11-02 10Q HAE/Haemonetics Quarterly
2023-08-08 10Q HAE/Haemonetics Quarterly
2023-02-07 10Q HAE/Haemonetics Quarterly
2022-11-08 10Q HAE/Haemonetics Quarterly
2022-08-10 10Q HAE/Haemonetics Quarterly

Receive HAE News And Ratings

See the #1 stock for the next 7 days that we like better than HAE

HAE Financial Statistics

Sales & Book Value

Annual Sales: $1.3B
Cash Flow: $35.2M
Price / Cash Flow: 47.54
Annual Sales: $18.05
Price / Book: 3.64

Profitability

EPS (TTM): 2.54000
Net Income (TTM): $130.1M
Gross Margin: $691.5M
Return on Equity: 14.16%
Return on Assets: 5.42%

Haemonetics Earnings Forecast

Key Haemonetics Financial Ratios

  • The Gross Profit Margin over the past 33 years for HAE is 52.83%.
  • The Selling, General & Administrative Expenses for HAE have been equal to 32.98% of Gross Profit Margin.
  • The Research & Development expenses have been 4.16% of Revenue.
  • The Interest Expense is 11.07% of Operating Income.
  • The Net Earning history of HAE is 8.98% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Haemonetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: HAE
CUSIP: 405024
Website: haemonetics.com

Debt

Debt-to-Equity Ratio: 1.35
Current Ratio: 3.97
Quick Ratio: 2.1

Price-to-Earnings

Trailing P/E Ratio: 28.68
Forward P/E Ratio: 13.17

HAE Technical Analysis vs Fundamental Analysis

Buy
58
Haemonetics (HAE) is a Buy

Is Haemonetics a Buy or a Sell?

  • Haemonetics stock is rated a Buy
    The current Haemonetics [HAE] share price is $65.93. The Score for HAE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.